Session » Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

Date: Monday, October 22, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1152

“Doctor, a Storm Is Coming and My Joints Hurt”: Evaluating Associations between Weather Changes and Arthritis Symptoms

9:00AM-11:00AM: Abstract Number: 1155

A Collaborative Cardio-Rheumatology Clinic for Primary Prevention of Cardiovascular Diseases – a Descriptive Study

9:00AM-11:00AM: Abstract Number: 1157

Acknowledged Biostatistical Help and the Quality of Statistical Analyses in Randomized Controlled Trials in Rheumatology

9:00AM-11:00AM: Abstract Number: 1125

Association between Hyperuricemia and Metabolic Syndrome with or without Obesity: Results from the 2016 Korea National Health and Nutrition Examination Survey

9:00AM-11:00AM: Abstract Number: 1161

Association of Knee Ligament and/or Meniscal Injury with Radiographic Knee Osteoarthritis in Military Officers

9:00AM-11:00AM: Abstract Number: 1136

Association of Mitochondrial DNA Haplotypes with Symptomatic Hand and Thumb Based Osteoarthritis and Hand OA Progression

9:00AM-11:00AM: Abstract Number: 1145

Association of Niacin Intake with Osteoporosis. the Cardiovascular Health Study

9:00AM-11:00AM: Abstract Number: 1139

Can Body Composition Explain the Sex Disparity in Risk of Osteoarthritis?

9:00AM-11:00AM: Abstract Number: 1140

Cause-Specific Mortality in Knee, Hip and Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1130

Chronic Risk Factors for Recurrent Gout Flares Among Established Gout Patients: A Prospective Cohort Analysis

9:00AM-11:00AM: Abstract Number: 1151

Comparison of Methodologic Approaches to Maximize the Validity of Fitbit Device Data for Arthritis-Related Research Purposes

9:00AM-11:00AM: Abstract Number: 1149

Contemporary Prevalence of Gout and Hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015-2016) and Decadal Trends (NHANES 2007-2016)

9:00AM-11:00AM: Abstract Number: 1132

Diet Modification for Gout Patients: Effects on Gout Attacks and Risk Factors for Metabolic Syndrome

9:00AM-11:00AM: Abstract Number: 1124

Epidemiological Characteristics of Inpatient Admissions for Acute Inflammatory Gout Arthropathy and Factors Affecting Length of Stay: A National Level Study

9:00AM-11:00AM: Abstract Number: 1153

EULAR ‘Points to Consider’ for the Conduction of Workforce Requirement Studies in Rheumatology

9:00AM-11:00AM: Abstract Number: 1133

Factors for Opioids Use in the Early Treatment Options for the Knee Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 1159

Fat Mass Is Associated with Musculoskeletal Pain in Women : A Three-Year Longitudinal Study

9:00AM-11:00AM: Abstract Number: 1135

Genome-Wide Meta-Analysis Identified Two Novel Variants Associated with Hallux Valgus

9:00AM-11:00AM: Abstract Number: 1147

Golimumab Improves Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA): 1-Year Results from a Non- Interventional Trial in Germany

9:00AM-11:00AM: Abstract Number: 1126

Gout and Chronic Pain in Older Adults: A Medicare Claims Study

9:00AM-11:00AM: Abstract Number: 1128

Impact of Urate-Lowering Therapy on the Risk of Cardiovascular Events and All-Cause Mortality Among Individuals with Gout

9:00AM-11:00AM: Abstract Number: 1160

Non-Elderly Adults Who Have Never Seen a Health-Care Provider for Chronic Joint Symptoms- Updated Results from National Health Interview Survey 2015

9:00AM-11:00AM: Abstract Number: 1154

Patterns of Opioid Use and Patient Characteristics before Total Hip and Knee Replacement

9:00AM-11:00AM: Abstract Number: 1143

Periodontal Disease Is Associated with an Increased Risk of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1137

Prediction Models for Poor Function Outcomes over 10 Years in Persons at High Risk for Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1129

Prevalence, Incidence, Determinants, and Impacts of Depression and Anxiety in Gout: A Systematic Review

9:00AM-11:00AM: Abstract Number: 1158

Privacy-Preserving Linkage between the Arthritispower Registry and Commercial Payer Claims Data to Support Comparative Effectiveness and Outcomes Research

9:00AM-11:00AM: Abstract Number: 1138

Public Health Impact of Physical Inactivity in the Knee OA Population in the US

9:00AM-11:00AM: Abstract Number: 1144

Risk of Osteoporotic Fractures in Patients with Rheumatoid Arthritis and End Stage Renal Disease. Findings from the Usrds Database

9:00AM-11:00AM: Abstract Number: 1127

Risk of Stroke Among Patients with Gout in Taiwan: A Nationwide Population Study

9:00AM-11:00AM: Abstract Number: 1134

Some Is Better Than None: Minimum Physical Activity Threshold to Prevent Disability in Older Adults with Lower Extremity Joint Symptoms

9:00AM-11:00AM: Abstract Number: 1146

The Association of Raas Inhibitor Use with Osteoporosis. Findings from the Women’s Health Initiative

9:00AM-11:00AM: Abstract Number: 1148

The Effects of Physical Activity on Bone Density of High School Girls: A Prospective Study

9:00AM-11:00AM: Abstract Number: 1150

The Potential Uses of an Infodemiology Approach for Health-Care Services in Rheumatology

9:00AM-11:00AM: Abstract Number: 1131

The Prevalence and Incidence of Gout, Its Associated Comorbidities and Treatment Pattern: An Epidemiological Study from Germany

9:00AM-11:00AM: Abstract Number: 1141

Trajectories of Extensive Sitting and Associated Predictors in Persons at High Risk for Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1142

Trend of Lymphoma Incidence in US Veterans with Rheumatoid Arthritis Vs Osteoarthritis: 2002-2017

9:00AM-11:00AM: Abstract Number: 1156

Work Productivity and Activity Impairment in Patients with Rotator Cuff Tendinopathy

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].